Clinical Trial Update: Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)

View source ↗

Summary

This document provides an update on Biohaven's expanded access protocol for Troriluzole in patients with Spinocerebellar ataxia, describing ongoing access to th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxia

Drugs mentioned

• Troriluzole (troriluzole)

Snippet

Sponsor: Biohaven Pharmaceuticals, Inc. | Conditions: SCA, Spinocerebellar Ataxias | Status: AVAILABLE